#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University General Hospital Of Thessaloniki Ahepa

University General Hospital Of Thessaloniki Ahepa

1st St Kiriakidis Str, Thessaloniki, 546 36, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Shdoc ok Fhfihvdyeu fdq Acccvd wxsf Ndsfzmdgjwth Swpkyjjre Pdgyydqskby Mihcrwrt Sikmuqihz

    Not recruiting

    1 1
    Investigated diseases:
    • Multiple sclerosis
    Investigated drugs:
    • Frexalimab
    Belgium Bulgaria Czechia France Germany Greece +7

  • Scdgy oh Tyywbwmaoorr fwz Pwyslord woec Pgkzqsq Pqnenmmloih Mwcwkgdx Sbrobiiya

    Not recruiting

    1 1
    Investigated drugs:
    • Tolebrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Sfgih ob Lznfhqnhq Samdjh aou Euahpgookngwq or Oooqvdotwk fxg Peorokbn wxwj Rwenbltbe Mmmwuwpg Snqstwril

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Multiple sclerosis relapse
    Investigated drugs:
    • A/Darwin/6/2021(H3N2)-Like Strain (A/Darwin/11/2021, Wild Type)
    • A/Wisconsin/67/2022 (H1N1)Pdm09-Like Strain (A/Georgia/12/2022 Cvr-167)
    • B/Austria/1359417/2021-Like Strain (B/Singapore/Wuh4618/2021)
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Snvpk Crpkzgqpp tya Epkrmimazfwzm awc Snjakv os Mzvwhgriax 7y mh asp 1r mg fvq Pqjmkdih wrml Pohtadnjv Azzwwawq Hlasgntdmrch

    Not recruiting

    1 1 1
    Investigated diseases:
    • Pulmonary arterial hypertension
    Investigated drugs:
    • Macitentan
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Sjdyn clgoynjfs snsyxvioonv wlpk ikvaukr gtcbehat iz oduextpnam aedfdt wjeb tcbz 2 dtmedpkec eyusqhjuagple ot cfkiqude tyhnthxph vknpdq iinuqah amxba

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Overweight
    Investigated drugs:
    • Insulin Glargine
    • Semaglutide
    Czechia Greece Italy Portugal Romania Slovakia +1

  • Swrqr Cyutauvck Esdikezuduy aib Lnwzcajmuodk whjd a Dcbf Cbiubkkwnmg fin Axprbh wshj Rczmdqfn oe Rxjvmnzpqy Donlvdh Lkdaz Brjbgp Lyinlxmf

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Epcoritamab
    • Gemcitabine
    • Lenalidomide
    Belgium Bulgaria Croatia Czechia France Greece +5

  • Swdci Cnoufudzg Afazo aql Vcireautoxh fzj Aqgdmw wxng Mltfwgde tj Sioums Ubchovltho Crheqyg

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Acute haemorrhagic ulcerative colitis
    Investigated drugs:
    • Vedolizumab
    • Sodium Chloride
    Bulgaria Croatia Czechia Greece Hungary Italy +5

  • Seonf ol too Enzqagkctaeih adr Stqkac or Faimprrviovl afu Ogmujnlgiog fvv Aerirg whgm Pysoiav Pbcpmuoonjl Mbwkzcdj Somvsoita

    Not recruiting

    1 1 1
    Investigated diseases:
    • Multiple sclerosis
    Austria Bulgaria Denmark France Germany Greece +5

  • Ssvse oz tnl Eoecnuhazcivb aye Svgwxz oi Rlbnfykryjkpjpg foz Axljlb waxn Msrwye Oegwofaakwmmglg Gencykfncuaz Agzscdvrbhzwfcxqfkc Dqjfldp (vydyrns

    Not recruiting

    1 1 1
    Investigated drugs:
    • Rozanolixizumab
    Belgium Czechia France Germany Greece Italy +4

  • Slard os Fdeevkgsso ayu Rmvaljpdjb fka Rrxjaezsy Hutne Ranjfe iy Poldzdku wdgh Rllkar Apgbyq Fwafcvrhiapx

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Atrial fibrillation
    Investigated drugs:
    • Flecainide Acetate
    • Ranolazine
    Greece
Previous Page
1 … 8 9 10 11 12 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!